Relamorelin

Enroll Now

Type of Study:

Adults 18 years and older with Type 1 or 2 Diabetes and Gastroparesis

Title of Study:

A study to evaluate the safety and efficacy of Relamorelin compared to placebo

Short Title:

RLM-MD-02

Study Length: 12 weeks

Target Age/Sex: 18 years and older, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Live better, healthier, smarter

Schedule an Appointment